Evestia Clinical
PrivateLast Round
Debt
Jul 1, 2025
Company Overview
Evestia Clinical is a pharmaceutical and biotechnology company that provides specialized contract research organization (CRO) services for clinical trials in oncology, rare diseases, and neurodegenerative conditions.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evestia Clinical Comparables
Compare Evestia Clinical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ergomed | 93% | |
| Veristat | 87% | |
| Caidya | 86% |
Evestia Clinical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 1, 2025 | ||||
| Buyout/LBO | Dec 9, 2024 |
Key People
Founding team and executive leadership
Evestia Clinical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kartesia | Debt |
| Kester Capital | Buyout/LBO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2025
Grew 53% QoQ, from 72 to 110 employees.
- Sep 5, 2025
Grew 24% QoQ, from 68 to 84 employees.
Evestia Clinical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Evestia Clinical's valuation, stock price, and market status.
Is Evestia Clinical a public or private company?
Evestia Clinical is a private company.
What is the current stock price of Evestia Clinical?
Evestia Clinical is a private company with no public stock price. Caplight tracks Evestia Clinical's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Evestia Clinical worth (valuation)?
Valuation information for Evestia Clinical is not publicly available.
Can I buy Evestia Clinical stock?
Evestia Clinical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Evestia Clinical's last funding round?
Evestia Clinical's most recent funding round was Debt on July 1, 2025.
Who are the main investors in Evestia Clinical?
Key investors in Evestia Clinical include Kester Capital.
Will Evestia Clinical IPO soon?
No public IPO plans have been announced for Evestia Clinical.
How can I track Evestia Clinical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Evestia Clinical's secondary market activity and sign up for updates.